The Biotech Industry Daily Monitor
Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on Fierce Biotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D.
Every business day, Fierce Biotech and its family of publications covers the waterfront in drug development and MedTech, from pre-clinical science to seed funding and venture capital, through IPOs and licensing, clinical testing, regulatory changes, M&A and beyond.
- Our aim is to not only report the news, but explain and analyze it. Learn not only what you need to know, but why you need to know it.
- We cover biotech companies from tiny, virtual startups to the biggest of Big Pharma, highlighting the accomplishments—and acknowledging the defeats—that all of them experience on their way to market with a new therapy.
- The Fierce Biotech team goes beyond the daily with comprehensive coverage of medical meetings and industry confabs, plus special reports that highlight up-and-comers and shed new light on industry heavyweights.